LATAMBif Registry: January 2021 Report

The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace. The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice. 

Bellow you will find data from January 2021, which includes all patients enrolled by the different Latin American centers taking part in the register. 

January data

So far, the registry has included 157 patients of mean age 65 (+- 10.86): 85% men, and 15% women.

Among the risk factors, we have found 84,6% had a history of hypertension, 78,2% dyslipidemia, 12,2% were smokers, 17,9% had type 2 diabetes and 2,6% had type 1 diabetes. In addition, 42,9% had prior PCI, 7,1% prior CABG and 26,9% prior MI.

Registro LATAM BIF - Reporte Mensual Enero 2021

Of all included patients, 37,2% presented chromic coronary syndrome, 26,9% unstable angina, 16,7% Non-ST acute myocardial infarction (NSTEMI), 12,2% were asymptomatic (silent ischemia) 7,1 ST elevation MI (STEMI).

As regards clinical indications, 55,1% received elective indication, 35,3% urgent indication and 9,6 emergency indication.

83,2% of vascular access was transradial (proximal), 3,9% transradial (distal) and12,9% femoral.

Registro Latam Bif - Reporte Mensual Enero 2021 - 2

As to the initial strategy, 71% was the provisional stent technique and 29% the two stent technique.

Registro Latam Bif - Reporte Mensual Enero 2021 - 3
monthly-report-january-2021

How to make part of the LATAM Bif Registry?

Write to latambif@gmail.com. You will receive all the information and documentation required for LATAMBif, coordinated by SOLACI Research.

Why take part in LATAM Bif?

  1. The chance to access your own database dedicated to coronary bifurcations, with unified variables for all centers across Latin America. 
  2. Each center will own their data and will be able to analyze outcomes in real time. 
  3. The chance to interact with centers interested in research and publication throughout the region. 
  4. The chance to present at local and international events the outcomes of LATAM Bif Registry.
  5. In case you might need help to develop research projects and/or carry out statistical analysis, you will have the support of SOLACI Research.
  6. SOLACI Research will provide weekly auditing for all data, initial and annual (mandatory followup), for it to be charged correctly. 

Write now to latambif@gmail.com and start participating of LATAM Bif.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...